Petros Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Petros Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2021.
  • Petros Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $10.5K, a 348% increase year-over-year.
  • Petros Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $0 +$1.43M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 -$1.43M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.